SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10359889
Source:
http://linkedlifedata.com/resource/pubmed/id/10359889
Search
Subject
(
66
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004048
,
umls-concept:C0004096
,
umls-concept:C0030705
,
umls-concept:C0073992
,
umls-concept:C0378466
,
umls-concept:C0442027
,
umls-concept:C1707455
pubmed:issue
6
pubmed:dateCreated
1999-7-7
pubmed:abstractText
Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a leukotriene receptor antagonist, are both indicated for the treatment of asthma in adolescent and adult patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/1275002
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol
,
http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotriene Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/salmeterol
,
http://linkedlifedata.com/resource/pubmed/chemical/zafirlukast
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0091-6749
pubmed:author
pubmed-author:BusseWW
,
pubmed-author:KalbergCC
,
pubmed-author:NelsonHH
,
pubmed-author:RickardK AKA
,
pubmed-author:WolffMM
,
pubmed-author:YanceyS WSW
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1075-80
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10359889-Administration, Inhalation
,
pubmed-meshheading:10359889-Administration, Oral
,
pubmed-meshheading:10359889-Adolescent
,
pubmed-meshheading:10359889-Adrenergic beta-Agonists
,
pubmed-meshheading:10359889-Adult
,
pubmed-meshheading:10359889-Aged
,
pubmed-meshheading:10359889-Albuterol
,
pubmed-meshheading:10359889-Asthma
,
pubmed-meshheading:10359889-Bronchodilator Agents
,
pubmed-meshheading:10359889-Circadian Rhythm
,
pubmed-meshheading:10359889-Double-Blind Method
,
pubmed-meshheading:10359889-Female
,
pubmed-meshheading:10359889-Humans
,
pubmed-meshheading:10359889-Leukotriene Antagonists
,
pubmed-meshheading:10359889-Lung
,
pubmed-meshheading:10359889-Male
,
pubmed-meshheading:10359889-Middle Aged
,
pubmed-meshheading:10359889-Respiratory Function Tests
,
pubmed-meshheading:10359889-Severity of Illness Index
,
pubmed-meshheading:10359889-Therapeutic Equivalency
,
pubmed-meshheading:10359889-Tosyl Compounds
pubmed:year
1999
pubmed:articleTitle
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
pubmed:affiliation
University of Wisconsin-Madison Medical School, Madison, WI, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study